DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Zhu AX, Rosmorduc O, Evans J , et al.
SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with hepatocellular carcinoma (HCC).

Ann Oncol 2012;
23 (Suppl. 09) Abstract LBA2

Download Bibliographical Data

Search in:
Access: